Merck won the first test of Vioxx in a federal court, though the short-term nature of the plaintiff’s use probably made it one of the weaker cases facing the company.
(“Merck wins retrial of first federal vioxx lawsuit”, Bloomberg, Feb 17). Ted Frank has more at Point of Law.
Comments are closed.